Yüklüyor......
Efficacy and safety of AZD3199 vs formoterol in COPD: a randomized, double-blind study
BACKGROUND: We investigated the efficacy and safety of AZD3199, a novel inhaled ultra-LABA, with the main aim of establishing a dose that would maintain 24-hour bronchodilation in patients with COPD. METHODS: Patients (n = 329) were randomized to AZD3199 (200, 400 or 800 μg o.d.), formoterol (9 μg b...
Kaydedildi:
| Asıl Yazarlar: | , , , , , , , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
BioMed Central
2013
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3691744/ https://ncbi.nlm.nih.gov/pubmed/23731768 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1465-9921-14-64 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|